Previous 10 | Next 10 |
2024-03-27 10:00:45 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run John...
2024-03-27 08:28:29 ET Losers: Direct Digital Holdings DRCT -44% after Q4 earnings release . LuxUrban Hotels LUXH -16% reports preliminary 2023 results . Altimmune ALT -31% after Q4 earnings release . Gamestop Corporation GME -18% after Q4 ear...
2024-03-26 16:42:37 ET Gainers: nCino ( NCNO ) +14% . Biomea Fusion ( BMEA ) +7% . Poseida Therapeutics ( PSTX ) +5% . Office Properties Income ( OPI ) +5% . Canopy Growth Corporation ( CGC ) +4% . Losers: Bow...
A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 36.6% to $0.0481 on volume of 589,492,515 shares Nikola Corporation (NKLA) rose 9.5% to $0.8139 on volume of 120,009,646 shares Tesla Inc. (TSLA) rose 2.9% to $177.67 on volume of 112,332,335 shares Direxion Da...
2024-03-26 14:28:43 ET DENVER, Colo., Mar 26, 2024 ( 247marketnews.com )- Today’s notable listings with recent news include KULR Technology Group, Inc. (NYSE: KULR ), (NYSE: LMT ), Mesoblast Limited (NASDAQ: MESO ), Canopy Growth Corporation (NASDAQ: CGC ), and ...
2024-03-26 12:55:48 ET More on Mid-day movers & stocks. Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Check-Cap jumps on Nobul AI business combination Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M...
Mesoblast Limited (NASDAQ: MESO) is one today's most active stocks by volume. So far today, approximately 29.43M shares of Mesoblast Limited have been exchanged, as compared to an average 30-day volume of 892.19k shares. Mesoblast Limited, a biopharmaceutical company, develops and commercializ...
2024-03-26 10:02:57 ET A %Biotech stock that has seen some pretty wild price swings as of late is turning heads so far during Tuesday’s premarket after the company was notified by the U.S. FDA that available clinical data from Phase 3 trial appeared sufficient to support BLA subm...
A look at the top 10 most actives in the United States C3is Inc. (CISS) rose 50.9% to $0.0531 on volume of 188,520,681 shares OpGen Inc. (OPGN) rose 64.8% to $0.783 on volume of 46,448,042 shares KULR Technology Group Inc. (KULR) rose 26.2% to $0.4102 on volume of 30,163,025 shares Tesl...
2024-03-26 06:53:18 ET More on Mesoblast Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript Mesoblast Limited 2024 Q2 - Results - Earnings Call Presentation Biggest stock movers today: EQT, MESO, Crypto-linked stocks, and more Mesoblast rises after cel...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 14:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for MESO on July 23, 2024 12:57PM ET. MESO was trading at $8.29 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 5 - Buy, 2 - H...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) resubmission for...
NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the confirmatory Phase 3 trial of its allogeneic, immunoselected, and industrially manufactured stromal cell product...